Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panagiota Drivelegka

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Annals of the Rheumatic Diseases|November 25, 2017
Work disability in gout: a population-based case-control studyValgerdur Sigurdardottir, Panagiota Drivelegka, Anna Svärd, et al.
Arthritis Care & Research|September 12, 2022
Incident Gout and Risk of First-Time Acute Coronary Syndrome: A Prospective, Population-Based Cohort Study in SwedenPanagiota Drivelegka, Lennart T H Jacobsson, Ulf Lindström, et al.
Arthritis Research & Therapy|June 2, 2018
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapyPanagiota Drivelegka, Valgerdur Sigurdardottir, Anna Svärd, et al.
Arthritis Research & Therapy|September 12, 2018
Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapyPanagiota Drivelegka, Valgerdur Sigurdardottir, Anna Svärd, et al.
Arthritis Research & Therapy|July 15, 2016
Incidence and prevalence of gout in Western SwedenMats Dehlin, Panagiota Drivelegka, Valgerdur Sigurdardottir, et al.
Rheumatology Advances in Practice|October 6, 2025
Association between gout, hyperuricaemia and Parkinson's disease risk: a cohort study in western Sweden (2001-2017)Mats Dehlin, Filip Bergquist, Panagiota Drivelegka, et al.
BMJ Open|February 28, 2025
Allopurinol use and risk of acute coronary syndrome in gout patients: a population-based cohort study in SwedenPanagiota Drivelegka, Lennart Jacobsson, Tatiana Zverkova Sandström, et al.
Arthritis Research & Therapy|February 24, 2020
Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS PilotPanagiota Drivelegka, Helena Forsblad-d'Elia, Oskar Angerås, et al.
JAMA Internal Medicine|January 26, 2026
Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients With GoutEdoardo Cipolletta, Tatiana Zverkova Sandström, Davide Rozza, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annals of the Rheumatic Diseases|November 25, 2017
Work disability in gout: a population-based case-control studyValgerdur Sigurdardottir, Panagiota Drivelegka, Anna Svärd, et al.
Arthritis Care & Research|September 12, 2022
Incident Gout and Risk of First-Time Acute Coronary Syndrome: A Prospective, Population-Based Cohort Study in SwedenPanagiota Drivelegka, Lennart T H Jacobsson, Ulf Lindström, et al.
Arthritis Research & Therapy|June 2, 2018
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapyPanagiota Drivelegka, Valgerdur Sigurdardottir, Anna Svärd, et al.
Arthritis Research & Therapy|September 12, 2018
Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapyPanagiota Drivelegka, Valgerdur Sigurdardottir, Anna Svärd, et al.
Arthritis Research & Therapy|July 15, 2016
Incidence and prevalence of gout in Western SwedenMats Dehlin, Panagiota Drivelegka, Valgerdur Sigurdardottir, et al.
Rheumatology Advances in Practice|October 6, 2025
Association between gout, hyperuricaemia and Parkinson's disease risk: a cohort study in western Sweden (2001-2017)Mats Dehlin, Filip Bergquist, Panagiota Drivelegka, et al.
BMJ Open|February 28, 2025
Allopurinol use and risk of acute coronary syndrome in gout patients: a population-based cohort study in SwedenPanagiota Drivelegka, Lennart Jacobsson, Tatiana Zverkova Sandström, et al.
Arthritis Research & Therapy|February 24, 2020
Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS PilotPanagiota Drivelegka, Helena Forsblad-d'Elia, Oskar Angerås, et al.
JAMA Internal Medicine|January 26, 2026
Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients With GoutEdoardo Cipolletta, Tatiana Zverkova Sandström, Davide Rozza, et al.
Pageof 1